ARAMON: A Phase 2, Randomized, Open-Label Study Comparing Darolutamide (DARO) Vs Enzalutamide (ENZA) Monotherapy on Serum Testosterone Levels in Patients (pts) with Castration-Sensitive Prostate Cancer (CSPC) after Biochemical Recurrence (BCR).
Journal of Clinical Oncology（2024）
Key words
261-436-2730,3282-3221-2748-2527,261-492-199-2823,261-492-3532-2370-7650-2700,613-615-646-2631,261-137,613-4678-146-349,60,60,2946,256,38092-27011,38092-27372,38092-25779
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined